The phrase "affordability challenge" is correct and usable in written English.
It can be used to describe a situation where the cost of something is too high for individuals or groups to manage, often in discussions about housing, healthcare, or education.
Example: "The city is facing an affordability challenge, making it difficult for many families to find suitable housing."
Alternatives: "cost barrier" or "financial hurdle".
And the affordability challenge does not affect everyone equally.
As a result, the affordability challenge will remain very much to the fore for many.
To address the affordability challenge, a sensible strategy would include changes like zoning that allows homes with units in the back or over the garage.
A failure to increase the supply of new homes to address this affordability challenge risks pricing people out of the city.
The idea for the app came from Devin Valencia, who won the Get Schooled Affordability Challenge against some 200 other entrants.
To some extent, this helps address the Washington area housing affordability challenge but does little for most of the thousands of households at the bottom of the income pyramid.
Lessons from cities that have been able to jumpstart their ADU market can help other places facing affordability challenges bring this innovation to scale.
Separate research from Which? this week claimed that shared ownership schemes, which have long been touted as a key part of the solution, also create their own affordability challenges.
Although rates in the 5's may sound reasonable to people who bought or refinanced a home a decade ago, they are disturbingly high to millennials and other young buyers and magnify the affordability challenges they already face.
In addition to textbook affordability challenges experienced by students, the panel also explored the dynamics of open textbook adoption, ancillary materials, student engagement with course materials, student outcomes, and ways to increase awareness of available open resources.
The drug board would include clinical experts and health-care economists and would be charged with identifying prescription drugs whose costs rose by specific amounts over one year and thus could cause "affordability challenges" for patients and the state health-care system.
